Mainstream Perp DEX Overview: TradeXYZ's trading volume surged yesterday but has since retraced, still holding a 45.7% share of Hyperliquid's total volume
BlockBeats News, April 9th, according to DefiLlama data, the HIP-3 ecosystem project TradeXYZ's trading volume, which doubled yesterday, has since fallen back. Hyperliquid's overall trading volume has returned to below 10 billion USD, with 45.7% of the volume coming from TradeXYZ's traditional market, placing EdgeX's trading volume in second. The current main Perp DEX trading volume rankings are as follows:
Hyperliquid: 24-hour trading volume is approximately 9.54 billion USD, with open interest of about 7.25 billion USD;
-tradeXYZ: 24-hour trading volume is approximately 4.36 billion USD, with open interest of about 1.69 billion USD;
EdgeX: 24-hour trading volume is approximately 2.30 billion USD, with open interest of about 1.03 billion USD;
Aster: 24-hour trading volume is approximately 1.92 billion USD, with open interest of about 1.87 billion USD;
Lighter: 24-hour trading volume is approximately 1.82 billion USD, with open interest of about 688 million USD;
Pacifica: 24-hour trading volume is approximately 471 million USD, with open interest of about 77.24 million USD;
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y
As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
Crypto prices
More
